Vor Biopharma Inc. (VOR)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS9290332074
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Vor Biopharma Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:02. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 16 Mar 2027 09:00 | -0.84 | — | — | Upcoming |
| 30 Oct 2026 08:00 | -0.72 | -0.90 | -25.3% | Miss |
| 14 Aug 2026 08:00 | -0.70 | — | — | — |
| 13 May 2026 08:00 | -0.78 | -0.73 | +7.2% | Beat |
| 30 Mar 2026 08:00 | -1.19 | 307.53 | +25,920.3% | Beat |
| 13 Nov 2025 16:00 | -4.10 | -121.63 | -2,866.6% | Miss |
| 12 Aug 2025 16:00 | -11.80 | -251.20 | -2,028.8% | Miss |
| 14 May 2025 16:00 | -4.16 | -5.20 | -25.0% | Miss |
| 20 Mar 2025 16:00 | -6.13 | -8.80 | -43.5% | Miss |
| 07 Nov 2024 16:00 | -0.40 | -8.00 | -1,904.4% | Miss |
| 08 Aug 2024 16:00 | -8.29 | -8.20 | +1.0% | Beat |
| 09 May 2024 16:00 | -7.63 | -9.00 | -18.0% | Miss |
| 20 Mar 2024 16:00 | -9.94 | -7.80 | +21.6% | Beat |
| 07 Nov 2023 16:00 | -9.17 | -9.80 | -6.9% | Miss |
| 10 Aug 2023 16:00 | -8.46 | -9.00 | -6.4% | Miss |
| 11 May 2023 16:00 | -7.77 | -8.60 | -10.7% | Miss |
| 23 Mar 2023 16:00 | -11.37 | -10.60 | +6.8% | Beat |
| 10 Nov 2022 16:00 | -11.89 | -12.60 | -6.0% | Miss |
| 11 Aug 2022 16:00 | -13.00 | -11.60 | +10.8% | Beat |
| 12 May 2022 16:00 | -10.29 | -12.20 | -18.6% | Miss |
| 14 Mar 2022 16:00 | -10.73 | -9.80 | +8.7% | Beat |
| 10 Nov 2021 16:00 | -11.50 | -10.00 | +13.0% | Beat |
| 09 Aug 2021 16:00 | -9.27 | -10.00 | -7.9% | Miss |
| 06 May 2021 16:00 | -15.20 | -13.40 | +11.8% | Beat |
| 25 Mar 2021 16:00 | -66.70 | -603.60 | -805.0% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 0 | — | -696M | — | -70.50 | -107.2% | -143.7M |
| 2024 | 0 | — | -116.9M | — | -34.03 | +2.8% | -99.9M |
| 2023 | 0 | — | -117.9M | — | -35.00 | +24.9% | -101.4M |
| 2022 | 0 | — | -92.1M | — | -46.60 | — | -93.6M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 19.70 | 20.62 | 18.82 | 18.97 | -4.58% | 2,735,134 | |
| 02 Nov 2026 – 06 Nov 2026 | 19.71 | 20.70 | 18.33 | 19.88 | +1.02% | 3,135,600 | |
| 26 Oct 2026 – 30 Oct 2026 | 18.33 | 21.74 | 17.70 | 19.68 | +7.78% | 3,981,100 | |
| 19 Oct 2026 – 23 Oct 2026 | 18.37 | 19.79 | 17.73 | 18.26 | +1.28% | 3,781,800 | |
| 12 Oct 2026 – 16 Oct 2026 | 19.79 | 20.52 | 18.00 | 18.03 | -9.40% | 4,173,400 | |
| 05 Oct 2026 – 09 Oct 2026 | 18.63 | 20.27 | 17.86 | 19.90 | +6.47% | 4,193,400 | |
| 28 Sep 2026 – 02 Oct 2026 | 18.36 | 19.81 | 17.52 | 18.69 | +0.92% | 5,033,500 | |
| 21 Sep 2026 – 25 Sep 2026 | 21.82 | 23.82 | 17.55 | 18.52 | -13.46% | 9,938,400 | |
| 14 Sep 2026 – 18 Sep 2026 | 22.39 | 23.56 | 21.23 | 21.40 | -4.04% | 8,382,200 | |
| 08 Sep 2026 – 11 Sep 2026 | 24.75 | 26.00 | 22.09 | 22.30 | -10.98% | 3,169,600 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Vor Biopharma Adds RC298 to RemeGen License Deal (opens in a new tab) MT Newswires · 12 Nov 2026 15:44
- Vor Biopharma (VOR) Stock Looks Reasonable After a 94% Five Year Slide (opens in a new tab) Simply Wall St. · 06 Nov 2026 21:11
- Vor Biopharma (VOR) Could Be 52% Undervalued As Phase 3 gMG Data Draw Focus (opens in a new tab) Simply Wall St. · 08 Oct 2026 16:17
- Durable MG Responses From Telitacicept Could Be A Game Changer For Vor Biopharma (VOR) (opens in a new tab) Simply Wall St. · 04 Oct 2026 17:05
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 19.32 USD
- Market cap
- 1.2B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow VOR and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.